| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.08 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |